eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 3 : 249-254 doi: ijmmas.2005.249.254
Research Article
"Is Expression of Mutational/ Deletional Genetic Lesions Determined Chiefly by Specifically Altered Myelin-axonal Interactions in Peripheral Neuropathy?"
Published
Sept. 30, 2005
Abstract

Simple pathways of interactive influence constituted by the Schwann cell and by a myelin sheath/axon complex might involve effective modes of induced expression of genetic lesions of a mutational or deletional type. Indeed, the Schwann cell itself would perhaps help characterize how such genetic lesions in hereditary peripheral neuropathy would be expressed in specific clinical forms of involvement that pathobiologically are demyelinative or axonal independent of actual distinction between dynamics of myelin deposition or axonal viability. In simple terms, one might perhaps realize paradoxical systems of expression and of progression of hereditary peripheral neuropathies inherent to disturbed control of genetic lesion expression. Indeed, disturbed gene expression as induced by mutation or deletion of genes would appear further modulated by essential attributes of myelin sheath and axonal interactions, as further reflected particularly in terms of Schwann cell participation. In terms of a range of types of peripheral neuropathies of hereditary and acquired type, mechanistic pathways of axonal and Schwann cell response would participate in actually creating various modulated forms of expression of gene interaction. Gene expression itself might itself constitute integrative interaction between neuronal axon and Schwann cell participation in peripheral neuropathies of both inherited and acquired type.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Factors Influencing Specialty Choice Among Medical Graduates: Determinants, Trends, and Implications for Healthcare Workforce Planning
27-32
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Burnout Among Medical Students and Residents: Prevalence, Risk Factors, and Impact on Academic and Clinical Performance
21-26
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.